Frazier Life Sciences Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Frazier Life Sciences Management’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,030,878	Closed	-$2.65M	–	55
2024 Q1	$2.65M	Hold	1,030,878	–	–	0.11%	48
2023 Q4	$2.1M	Sell	1,030,878 -400,000	-28%	-$730K	0.11%	47
2023 Q3	$2.46M	Sell	1,430,878 -970,836	-40%	-$1.72M	0.16%	47
2023 Q2	$4.68M	Sell	2,401,714 -2,760,634	-53%	-$6.46M	0.28%	43
2023 Q1	$14.4M	Hold	5,162,348	–	–	1.04%	24
2022 Q4	$17.8M	Sell	5,162,348 -75,000	-1%	-$214K	1.11%	21
2022 Q3	$13.5M	Hold	5,237,348	–	–	1.04%	24
2022 Q2	$12.7M	Hold	5,237,348	–	–	1.2%	22
2022 Q1	$21.6M	Buy	+5,237,348	New	+$27.7M	1.84%	18

Other funds holding GRTS

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Frazier Life Sciences Management's GRTS Position: Q2 2024 in Review

Frazier Life Sciences Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2024, closing a stake of 1,030,878 shares — an estimated $2.65M sold.

Frazier Life Sciences Management first reported a position in GRTS in Q1 2022 and held it in 9 quarters. The position peaked at $21.6M in Q1 2022. 79 funds tracked by Wall St. Rank hold GRTS as of Q2 2024.

Frazier Life Sciences Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Frazier Life Sciences Management sold 1,030,878 Gritstone bio, Inc. Common Stock shares in Q2 2024, an estimated $2.65M.
Frazier Life Sciences Management first reported a position in Gritstone bio, Inc. Common Stock in Q1 2022 and held it in 9 quarters.
Frazier Life Sciences Management's Gritstone bio, Inc. Common Stock position peaked at $21.6M in Q1 2022.
79 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2024.

Based on Frazier Life Sciences Management's 13F filing for Q2 2024, filed 15 Aug 2024.